Comment
doi: 10.1016/j.immuni.2023.10.012.
Illuminating the dark side of neuraminidase in influenza immunity
Affiliations
- PMID: 37967527
- DOI: 10.1016/j.immuni.2023.10.012
Item in Clipboard
Comment
Illuminating the dark side of neuraminidase in influenza immunity
Immunity.
.
Abstract
The influenza neuraminidase has historically been understudied compared to its surface protein counterpart, hemagglutinin. In two recent Immunity papers, Hansen et al. and Lei et al. bolster resurging interest in neuraminidase-targeting antibodies and their implications for therapy and "universal" vaccines.
Copyright © 2023 Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of interests The author declares no competing interests.
Comment on
-
Human anti-N1 monoclonal antibodies elicited by pandemic H1N1 virus infection broadly inhibit HxN1 viruses in vitro and in vivo.Immunity. 2023 Aug 8;56(8):1927-1938.e8. doi: 10.1016/j.immuni.2023.07.004. Epub 2023 Jul 27. Immunity. 2023. PMID: 37506693 Free PMC article.
-
Leveraging vaccination-induced protective antibodies to define conserved epitopes on influenza N2 neuraminidase.Immunity. 2023 Nov 14;56(11):2621-2634.e6. doi: 10.1016/j.immuni.2023.10.005. Immunity. 2023. PMID: 37967533 Free PMC article.